Insider · CIK 0001721442

Mark Sabag

officer

Files at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD). First filing May 12, 2025, latest May 12, 2025.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

0 / 1

$0 bought, $6.1M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TEVA: TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVAOct 9, 2026 · close 41.10

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
60Notable	TEVAsell TEVA PHARMACEUTICAL INDUSTRIES LTD	$6.1M 337,915 shares	-69%	+41% from low-21% from high	May 12, 2025

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
May 8, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SOpen-market sale Ordinary Shares	-337,915	$18.04	$6.1M	150,996	May 12, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.